Media Pack
News

Current Edition

Volume 16 Issue 1
 
Asia Pacific

Jeil Pharma unveils new research centre

The new research centre is part of the company’s plans to strengthen investment in the R&D sector. Jeil Pharmaceutical has recently opened a new technology rese...
23 May 2018 Asia Pacific | Europe centre | jeil
Continue Reading →
Europe

Genoscience Pharma extends its first clinical trial of GN561 in patients with advanced liver cancers to France

Enrollment is open for patients with intrahepatic cholangiocarcinoma and hepatocarcinoma at Croix-Rousse Hospital in Lyon and at Saint-Joseph Hospital in Paris Genos...
23 May 2018 Europe cancer | clinical
Continue Reading →
news

ICON announces agreement with Intel allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials

ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announ...
18 April 2018 news ICON | Integration
Continue Reading →
Asia Pacific

Janssen to begin phase 2 clinical trials of Hanmi Pharma’s diabetes drug

US pharmaceutical company Janssen will start carrying out phase 2 clinical trials in the US to evaluate the efficacy and safety of a diabetes drug candidate originall...
4 April 2018 Asia Pacific | Europe clinical | diabetes
Continue Reading →
news

Bioethics International Releases Second Good Pharma Scorecard

Bioethics International announced the second publication of its Good Pharma Scorecard ("GPS"), an annual index ranking large pharmaceutical companies and new drugs on...
13 December 2017 news clinical trial | ethics
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte